NYLJ: J&J Knew Cancer Risks Associated with Talc Products
December 16, 2016 | Pharmaceutical Litigation
Johnson & Johnson has known about the increased ovarian cancer risk associated with the use of their talc-based products but failed to warn women who used it. In fact, the supposed family friendly company did nothing, not even putting a warning label on the box despite the numerous research studies showing the connection between talcum powder and ovarian cancer.
These studies go back over 40 years and have resulted in the recommendation by the scientists involved that Johnson & Johnson should place a warning on its talcum powders about the ovarian cancer risks so that women could make an informed decision about their health. Still the company did not let women know that there is a significant risk associated with their health and the use of their products.
Jurors have been presented with the evidence and agree with the dangers associated with Johnson & Johnson’s products and awarded an 8-figure verdict in a trial charging the company knew its talc-based Baby Powder and Shower to Shower Powder causes ovarian cancer, and failed to warn women who used it.
As one juror, Jerome Kendrick, put it, “They (Johnson & Johnson) tried to cover up and influence the boards that regulate cosmetics.” He went on to say that the company’s internal memos “pretty much sealed myopinion…they could have at least put a warning label on the box but they didn’t.”
Read the full New York Law Journal article.